FindTrial
Sign In

A study to evaluate the effectiveness of a newly formulated solution containing ellagic acid and sodium hyaluronate compared to standard treatment for enhancing eyelash growth.

Formulation of topical solution / ointment incorporating ellagic acid and sodium hyaluronate and evaluating their relative effectiveness in promoting eyelash growth comparing with standard treatment. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077449
Enrollment
50
Registered
2024-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H029- Unspecified disorder of eyelid

Interventions

Intervention1: SODIUM HYALURONATE, ELLAGIC ACID: The topical solution contains 30 mg of ellagic acid and 0.5 g of sodium hyaluronate per 5 mL bottle. It is applied topically to the eyelash area twice

Sponsors

Dr V Pavithra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ADULT PARTICIPANTS AGED MORE THAN 18 YEARS, WHO DESIRE FOR EYELASH ENHANCEMENT

Exclusion criteria

Exclusion criteria: Patients unwilling to provide informed consent. Allergy to ellagic acid products. Prior use of steroids or topical ointments. Systemic treatment within the last 30 days. Pregnancy or lactation. History of sunburns, phototoxicity, scars, rashes, or active skin diseases.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be the relative effectiveness of the topical solution compared to standard treatment in promoting eyelash growth.Timepoint: 3 months—

Secondary

MeasureTime frame
participant satisfactionTimepoint: 3 month—

Countries

India

Contacts

Public ContactDivya N

Saveetha medical college and hospital

Divya.q7@gmail.com7299933288

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026